Growth Metrics

ENDRA Life Sciences (NDRA) Retained Earnings (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Retained Earnings for 6 consecutive years, with -$65.6 million as the latest value for Q3 2021.

  • Quarterly Retained Earnings fell 19.06% to -$65.6 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$65.6 million through Sep 2021, down 19.06% year-over-year, with the annual reading at -$57.3 million for FY2020, 26.81% down from the prior year.
  • Retained Earnings for Q3 2021 was -$65.6 million at ENDRA Life Sciences, down from -$62.9 million in the prior quarter.
  • The five-year high for Retained Earnings was -$13.3 million in Q1 2017, with the low at -$65.6 million in Q3 2021.
  • Average Retained Earnings over 5 years is -$37.0 million, with a median of -$32.8 million recorded in 2019.
  • The sharpest move saw Retained Earnings crashed 63.29% in 2019, then fell 19.06% in 2021.
  • Over 5 years, Retained Earnings stood at -$17.9 million in 2017, then tumbled by 54.74% to -$27.7 million in 2018, then tumbled by 63.29% to -$45.2 million in 2019, then dropped by 26.81% to -$57.3 million in 2020, then fell by 14.38% to -$65.6 million in 2021.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$65.6 million, -$62.9 million, and -$59.7 million for Q3 2021, Q2 2021, and Q1 2021 respectively.